It is increasingly important to identify these patients who are at high risk of developing pneumonia so that targeted treatment, such as adjustment of chemotherapy drug regimen and dose and post-treatment support measures such as G-CSF, can be administered. The gene discussed is CSF3; the disease is susceptibility to pneumonia measurement.